Kent Rogers

Kent Rogers Email and Phone Number

President, PBM @ CarelonRx
Irvine, CA, US
Kent Rogers's Location
Irvine, California, United States, United States
Kent Rogers's Contact Details

Kent Rogers personal email

n/a

Kent Rogers phone numbers

About Kent Rogers

EveryONE Medicines is committed to developing individualized precision therapeutics targeting genetic variants causing severe central nervous system diseases, even if unique to just one person. Together we can bring individualized precision therapeutics to people across the globe who currently don’t have effective therapies. We can take the haphazardness out of the diagnosis and speed the process toward treatment.Now is the time. Momentum is building as the technology to identify even the rarest of rare mutations is becoming better.Our story begins with Mila’s. After a happy and seemingly healthy first few years of childhood, Mila was diagnosed with a rare fatal neurodegenerative disease. In a ground-breaking race against time, Dr. Timothy Yu of Boston Children’s Hospital developed milasen, an antisense oligonucleotide targeting Mila’s unique mutation. Mila became the first person in the world to receive a medicine tailored to just one person. Since then, Mila’s mother, Julia Vitarello, has been on a mission to turn the work for Mila into a new mainstream way of solving the global crisis of rare disease in children. Julia co-founded EveryONE Medicines with the hope of creating a viable business model to bring this approach to all patients who could benefit. Together, we are working toward a future where individualized medicines are routine.

Kent Rogers's Current Company Details
CarelonRx

Carelonrx

View
President, PBM
Irvine, CA, US
Kent Rogers Work Experience Details
  • Carelonrx
    President, Pbm
    Carelonrx
    Irvine, Ca, Us
  • Everyone Medicines
    Chief Executive Officer
    Everyone Medicines Jul 2024 - Present
    Boston, Ma, Us
  • Slaterx
    Board Member
    Slaterx Jan 2024 - Present
  • Arch Venture Partners
    Venture Partner
    Arch Venture Partners Jul 2023 - Present
    Chicago, Il, Us
    For over 30 years, ARCH has backed disruptive science companies with as little as $50K to as much as hundreds of millions of dollars, per company. We are committed to building innovative companies that impact and improve human health and take a long-term view when building companies. The firm is a recognized leader in commercializing technologies developed at academic institutions, corporate research groups and national laboratories. We invest primarily in companies we co-found with leading scientists and entrepreneurs, bringing innovations in life sciences and physical sciences to market.
  • Eqrx
    Chief Commercial Officer (Cco)
    Eqrx Apr 2021 - Jul 2023
    Responsible for the build and operations of all strategic commercialization functions for pipeline assets in oncology and immunology disease states including; marketing, sales, product distribution, commercial operations, payer strategy and payer/provider contracted partnerships (US and ex-US – emphasis in the EU). The commercial model was non-traditional with an emphasis on Payer/Provider partnership agreements and digital marketing strategies to drive market adoption vs. investment in traditional, large field-based commercial functions. We successfully secured unique contract agreements with payers inclusive of the VHA, national PBMs, and regional payers which required the payers to pull through market adoption for hundreds of millions of insured lives in the US.
  • Optum
    Svp, Chief Industry Relations Officer
    Optum Feb 2016 - Apr 2021
    Eden Prairie , Mn, Us
    SVP, Chief Industry Relations Officer for OptumRx, a division of Optum under the United Health Group enterprise. Had leadership over the Commercial & Medicare formulary contracting strategy for all books of business, Optum Specialty & Infusion contracting strategies, and client services strategies which include FFS Medicaid and a Formulary Consulting Group. Responsible for over $16B in Specialty drug procurement and over $95B in annual drug spend for all books of internal and external business with United Health Group’s United Healthcare and OptumRx PBM operations.
  • Blue Fin Group, An Integrichain Company
    Principal
    Blue Fin Group, An Integrichain Company Jul 2013 - Jan 2016
    Philadelphia, Pa, Us
    Blue Fin Group is a professional consulting firm with mature project and engagement skills and methodologies working for a wide array of branded pharmaceuticals, biotech, generics, consumer health, and medical device manufacturers in the area of sales and marketing product program management. Deep experience and proven success assessing and developing strategies for manufacturers across a broad range of company size, portfolios, and lifecycles.Blue Fin provides tailored intelligence on the healthcare industry. We conduct seminars, summits, environmental scans, articles and white papers, full training sessions, and custom research efforts with read-outs. Blue Fin conducts two independent types (or phases) of consulting projects: strategy development and implementation. In the strategy development phase, our goal is a high-level business case and strategic roadmap that informs a team what is being done, why, how long it takes, what it costs and who is responsible for it. In the implementation phase, the end goal is the deployment of the solution.
  • Acorda Therapeutics
    Vice President - Global Market Access
    Acorda Therapeutics 2008 - 2013
    Pearl River, New York, Us
    Led the development and deployment of the first Managed Markets department in company history which included; field-based account managers, field-based reimbursement specialists, field-based Directors, and home-office based personnel (Payer Strategy, Trade/Channel Strategy, Contracting/Pricing) to support all activities related to reimbursement for pipeline and in-licensed promoted products. Oversaw P&L which included all costs associated with direct reports, as well as, budget spend on a Patient Support Services HUB, Co-Pay Mitigation Programs, Patient Assistance Programs and third-party logistics product distribution (3PL). Served on the Executive Steering Committee for the Acorda Mentorship Program, the Business Development Advisory Counsel in all matters associated with prospective product in-licensing, acquisition, or co-promotion, the Joint Commercial Committee as part of an international marketing agreement with Biogen-Idec, Inc, and the Quality Review Committee – a committee of VPs from multiple departments responsible for oversight of pharmacovigilence, adverse event reporting, and adherence to FDA REMS reporting requirements.
  • Merck
    Director, Marketing Strategy
    Merck Sep 2004 - Sep 2008
    Rahway, New Jersey, Us
    Led and managed a team responsible for the development and implementation of marketing strategies to support over 100 field based account managers in therapy areas of cardiovascular disease, CNS, Oncology and Hepatitis C. Managed all aspects of promotional materials and marketing programs through a legal and regulatory approval process. Served on executive team for the review and approval of contract proposals for all books of business including; commercial HMO/PBM, Medicaid, Medicare Part D, federal markets and hospital systems. Developed the U.S. pricing/reimbursement launch strategy for multiple products totaling over $15 billion in annual sales.
  • Schering Pharmaceuticals
    National Sales Specialist - Various Roles
    Schering Pharmaceuticals Nov 1994 - Sep 2004
    Kenilworth, Nj, Us
    Various leadership roles as National Account Executive with Merck/Schering Plough, National Account Manager with Schering Plough, Oncology & Biotech Sales Specialist and Primary Care Sales Representative.

Kent Rogers Skills

Managed Care Strategy Pharmaceutical Industry Oncology Biotechnology Leadership Strategic Planning Product Launch Business Development Healthcare Clinical Trials Market Research Program Management Management Medical Devices Marketing Marketing Strategy Mergers And Acquisitions Integrity Team Leadership Government Contracting

Kent Rogers Education Details

  • Emory University - Goizueta Business School
    Emory University - Goizueta Business School
    International Business
  • Indiana University Bloomington
    Indiana University Bloomington
    Business Management & Organizational Change
  • Parkway West
    Parkway West

Frequently Asked Questions about Kent Rogers

What company does Kent Rogers work for?

Kent Rogers works for Carelonrx

What is Kent Rogers's role at the current company?

Kent Rogers's current role is President, PBM.

What is Kent Rogers's email address?

Kent Rogers's email address is ke****@****msn.com

What is Kent Rogers's direct phone number?

Kent Rogers's direct phone number is (206) 622*****

What schools did Kent Rogers attend?

Kent Rogers attended Emory University - Goizueta Business School, Indiana University Bloomington, Parkway West.

What skills is Kent Rogers known for?

Kent Rogers has skills like Managed Care, Strategy, Pharmaceutical Industry, Oncology, Biotechnology, Leadership, Strategic Planning, Product Launch, Business Development, Healthcare, Clinical Trials, Market Research.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.